IP Library Patent Application 16600226
Patent Application
App. No. 16/600,226

SYSTEM AND METHOD FOR APPLICATION OF ENHANCED CONTROLS WITH A GENOMIC COMPUTING PLATFORM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/600,226
Abstract

A system and method for genomic sample processing in a computing system using an enhanced spike-in that includes specifying a genetic control sequence; registering the genetic control sequence to a genetic database of the computing system; in association with a genomic sample, detecting a detected instance of the control sequence in a collection of genetic data collected for the genomic sample; and augmenting sample management of the genomic sample within the computing system according to the detected instance of the control sequence.

Claims (37)

1 . A method for genomic sample processing in a computing system comprising:

specifying a genetic control sequence;

registering the genetic control sequence to a genetic database;

in association with a genomic sample, detecting a detected instance of the control sequence in a collection of genetic data collected for the genomic sample; and

augmenting sample management of the genomic sample within the computing system according to the detected instance control.

2 . The method of claim 1 , wherein specifying the genetic control sequence comprises encoding information into the genetic control sequence through an error-correcting code; wherein detecting the detected instance of the control sequence comprises decoding the control sequence and obtaining result information; and wherein augmenting sample management is at least partially based on the result information.

3 . The method of claim 2 , wherein encoding information into the genomic control sequence comprises encoding the information into the genomic control sequence through an error correcting code using a repetition code.

4 . The method of claim 3 , wherein the repetition code is a binary repetition code of length three.

5 . The method of claim 3 , wherein the repetition code is a Hamming code.

6 . The method of claim 2 , wherein encoding information into the genomic control sequence comprises:

generating a template binary sequence,

transforming the information into a base four data message,

encoding the base four data message with a repetition code,

applying a bitwise exclusive-or operator to the template binary sequence and the encoded sequence, and

outputting the genomic control sequence yielded from successfully encoding the information.

7 . The method of claim 6 , wherein the repetition code is a Hamming code.

8 . The method of claim 6 , wherein encoding information into the genomic control sequence comprises: after applying the bitwise XOR operation, validating a set of control conditions for the resulting control sequence, and, if a control condition is not satisfied, generating an updated control sequence by encoding the information using a different random template binary sequence.

9 . The method of claim 2 , wherein decoding the control sequence thereby obtaining result information comprises:

accessing a template binary sequence,

applying a bitwise exclusive-or operator to the template binary sequence and the detected control sequence,

decoding the repetition encoding, and

converting from base four representation thereby yielding the result information.

10 . The method of claim 2 , further comprising obtaining a control sample that exhibits a genetic signature based on the control sequence.

11 . The method of claim 10 , wherein obtaining a control sample based on the control sequence comprises synthesizing the control sample.

12 . The method of claim 10 , wherein obtaining a control sample based on the control sequence comprises transmitting a synthesis request that specifies the control sequence as a requested control sample.

13 . The method of claim 10 , further comprising producing a sample collection device prepared with the control sample, wherein the sample collection device is used in association with the genetic sample.

14 . The method of claim 2 , further comprising establishing an association between the genomic sample and a control sample in the computing system, detecting an anomaly in processing a genomic sample based on detection of the result information and the association with the control sample, and generating an alert.

15 . The method of claim 1 , wherein the genetic control sequence is an organic control sequence.

16 . The method of claim 15 , wherein the genetic control sequence is registered as a positive control; and wherein augmenting sample management of the genomic sample comprises processing the genomic sample as a positive control and automatically reporting at least the contamination level of the positive control.

17 . The method of claim 1 , wherein augmenting sample management of the genomic sample within the computing system comprises: setting a data association of the result information and the collection of genetic data collected for the genomic sample; and presenting the result information in a user interface.

18 . The method of claim 17 , wherein the genetic control sequence is a synthetic control sequence; and further comprising:

specifying at least a second control, wherein the second control sequence is an organic control sequence and at the computer database of the computing system, registering the genetic control sequence; and

in association with a second genomic sample, detecting a detected instance of the second control sequence in a second collection of genetic data collected for the second genomic sample;

augmenting sample management of the second genomic sample within the computing system according to the detected instance of the second control sequence, which comprises processing the second genomic sample as a positive control.

19 . The method of claim 1 , wherein augmenting sample management of the genomic sample within the computing system comprises generating a process alert in the computing system in response to conditions of the result information.

20 . The method of claim 1 , wherein augmenting sample management of the genomic sample within the computing system comprises altering operation of experimental equipment according to the result information.

21 . The method of claim 1 , where augmenting sample management of the genomic sample within the computing system comprises estimating a quantity of detected sequences based on relative detection of a control sequence.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2022
From: INVITAE CORPORATION
To: ONE CODEX, INC.
Reel/Frame 061288/0078 →
RELEASE OF SECURITY INTEREST Recorded Sep 22, 2022
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: INVITAE CORPORATION
Reel/Frame 061177/0051 →
MERGER AND CHANGE OF NAME Recorded Sep 14, 2021
From: REFERENCE GENOMICS, INC.; ORION MERGER SUB B LLC
To: REFERENCE GENOMICS, LLC
Reel/Frame 057477/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2021
From: REFERENCE GENOMICS, LLC.
To: INVITAE CORPORATION
Reel/Frame 057477/0655 →
SECURITY INTEREST Recorded May 18, 2021
From: REFERENCE GENOMICS, LLC
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056280/0559 →
MERGER AND CHANGE OF NAME Recorded May 18, 2021
From: REFERENCE GENOMICS, INC.; ORION MERGER SUB B LLC
To: REFERENCE GENOMICS, LLC
Reel/Frame 056280/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2020
From: BOVEE, RODERICK JOCK; GREENFIELD, NICHOLAS BOYD
To: REFERENCE GENOMICS, INC.
Reel/Frame 052934/0298 →